Elevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma

Key Points

• This research explores the role of DOCK4 as a prognostic biomarker in clear cell renal cell carcinoma (ccRCC).
• Analyzed DOCK4 expression levels in ccRCC samples
• Evaluated correlation between DOCK4 expression and pathologic staging
• Examined impact on survival rates
• Investigated the role of DOCK4 in tumor immune microenvironment (TIME)
• High DOCK4 expression correlates with favorable pathologic staging
• Patients with elevated DOCK4 have improved survival
• DOCK4 may serve as a therapeutic target for immunotherapy in ccRCC